Medication Description: Catalin (Catalin)
Sodium salt of 1-hydroxy-5-oxo-5H-pyrido (3, 2-a) -phenoxazine-3-carboxylic acid.
Synonyms: Sancatalin, Clarvisan, Clarvisor, Pirenoxine sodium.
It is used in the form of eye drops as a means of inhibiting the development of cataracts (See also Cysteine, Vice, Catahrom.).
The mechanism of action of catalina is not well understood. It is believed that the drug inhibits the action of quinone compounds, which are products of the disturbed metabolism of the lens. The drug stabilizes the membrane, to some extent inhibits lipid peroxidation.
Catalin is used for the prevention of progressive early senile cataracts and diabetic cataracts.
Available in vials containing 15 ml of solvent, with the addition of a tablet containing 0.75 mg of catalina.
To prepare the solution, immerse the tablet in a vial with a solvent (without violating sterility). After dissolving the tablet, a clear yellow solution is formed.
Instill 1 to 2 drops in the conjunctival sac 5-6 times a day. Apply for a long time.
Usually, the drug is well tolerated, but surface keratitis, blepharitis, itching, and pain may occur. When expressed by the side effects of the drug is stopped.
Product: in bottles with unscrewed caps with sterile tablets in special packaging.
Storage: protected from light, cool place. The finished solution is suitable for use within a month.
There is a foreign dosage form, containing, together with 0.75 mg of cataline (pyrenoxine sodium), 62 mg of taurine (see Taufon).
Sankatalin and Catalin are produced in Japan.